Senior insider sale
Chief Financial Officer at VOYAGER THERAPEUTICS, INC. — senior position signals high conviction
$17.6K
4.67K shares
What this filing means
JORGENSEN NATHAN D. plans to sell 4.67K shares of VOYAGER THERAPEUTICS, INC. valued at approximately $17.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/24/2026ACC: 0001959173-26-001449
Officer· Chief Financial Officer
Since Feb 2026
4.67K
Shares to sell
$17.6K
Approx. market value
4.67K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/20/2026
4.67KTotal acquired4.67K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/20/2026 | Restricted Stock Vesting Compensation | 4.67K | — |
| Total | 4.67K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
4.67K
Market value
$17.6K
2/24/2026
Total
Units
4.67K
Value
$17.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/24/2026 | 4.67K | $17.6K | NASDAQ | Planned |
| Total | 4.67K | $17.6K | ||